Antiphospholipid antibodies and reproductive failure

Chemical Immunology and Allergy

Volumn 88, Issue , 2005, Pages 139-149

  Ulcova Gallova, Z ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIIDIOTYPIC ANTIBODY; ANTIMALARIAL AGENT; ANTITHROMBOCYTIC AGENT; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; COMPLEMENT INHIBITOR; CORTICOSTEROID; GLYCEROL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 3; LIPOCORTIN 5; MONOCLONAL ANTIBODY; NADROPARIN; PHOSPHOLIPID ANTIBODY; SERINE;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; DRUG ABUSE; GRAFT REJECTION; HUMAN; HYPERTENSION; INFECTION; INFERTILITY; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; METABOLIC DISORDER; NEUROENDOCRINE DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PH; PREECLAMPSIA; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; THROMBOSIS;

ABORTION, SPONTANEOUS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; NEUROSECRETORY SYSTEMS; PREGNANCY;

EID: 30744460639     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000087831     Document Type: Review

References (52)

1. Wasserman A: Über die Entwicklung und den gegenwärtigen Stand der Serodiagnostik gegenüber Syphilis. Berl Klin Wochenschr 1907;44:1599-1605.
2. Pangborn MC: A new serologically active phospholipids from beef heart. Proc Soc Exp Biol Med 1941;48:484-486.
3. Conley CL, Hartman RC: Haemorrhagic disorders caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952;31:621-626.
4. Laurell A, Nilsson IM: Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wasserman reaction. J Lab Clin Med 1957;49:694-707.
5. Shapiro SS, Thiagarajan P: Lupus anticoagulants. Prog Hemost Thromb 1982;6:263-285.
6. Harris EN, Ghavari AE, Boey ML: Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;ii:1211-1214.
7. Loizou S, McCrea JD, Rudge AC: Measurement of anticardiolipin antibodies by an enzyme linked immunosorbent assay (ELISA): Standardisation and quantitation of results. Clin Exp Immunol 1985;62:738-745.
8. Harris EN, Gharavi AE, Wasley GD, Hughes GRV: Use of an enzyme-linked immunosorbent assay and inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis 1988;157:23-31.
9. Koike T, Sueishi M, Funaki H: Antiphospholipid antibodies and biological false positive serological tests for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984;56:193-199.
10. Olhoffer IH, Peng SL, Craft J: Revisiting autoantibody profiles in systemic lupus erythematosus. J Rheumatol 1997;24:297-302.
11. Mills JA: Systemic lupus erythematosus. N Engl J Med 1994;330:1871-1879.
12. McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991;49:193-279.
13. Asheron RA, Cervera R: Antiphospholipid antibodies and infectious. Ann Rheum Dis 2003;62:388-393.
14. Vaarla O, Puurunen M, Manttari M, Manninen V, Aho K, Palosuo T: Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost 1996;75:456-459.
15. Asherson RA: The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-512.
16. Briley DP, Coull BM, Goodnight SH: Neurological disease associated with antiphospholipid antibodies. Ann Neurol 1989;44:221-227.
17. Shoenfeld Y, Lev S, Blatt I: Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol 2004;31:1344-1348.
18. Singer HS, Krumholz A, Giuliano J, Kiessling LS: Antiphospholipid antibodies: An epiphenomenon in Tourette syndrome. Mov Disord 1997;12:738-742.
19. Mori T, Takai Y, Minakuchi R: Inhibitory action of chlorpromazine, dibucaine and other phospholipid-interacting drugs on calcium-activated phospholipid-dependent protein kinase. J Biol Chem 1980;225:8378-8380.
20. Chedid A, Kurmanadha CR, Morgan TR, Moritz TE, Mendenhall CL, Hammong JB: Antiphospholipid antibodies in alcoholic liver disease. Hepatology 1994;31:141-142.
21. Gargiulo P, Goldberg J, Romani B, Schiaffini R, Ciampalini P, Faulk WP: Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus. Clin Exp Immunol 1999;118:30-34.
22. Wagenknecht DR, Becker DG, LeFor WM, McIntyre JA: Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 1999;68:241-246.
23. McIntyre JA, Wagenknecht DR, Faulk WP: Antiphospholipid antibodies: Discovery, definitions, detection and disease. Prog Lipid Res 2003;42:176-237.
24. Passam FH, Krilis SA: Laboratory tests for the antiphospholipid syndrome: Current concepts. Pathology 2004;36:129-138.
25. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999;42:1309-1311.
26. Graves M: Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348-1353.
27. Koike T: Antiphospholipid syndrome; mechanism of thrombus formation and complication of reproductive system. Am J Reprod Immunol 2004;51:457.
28. Sthoeger ZM, Mozes E, Tartakovsky B: Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA 1993;90:6464-6467.
29. Triplett DA: Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989;20:52-67.
30. Rai R: Obstetric management of antiphospholipid syndrome. J Autoimmun 2000;15:203-207.
31. Kwak JY, Gilman-Sachs A, Beaman KD, Beer AE: Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology. J Reprod Immunol 1992;22:15-31.
32. Lockshim MD, Erkan D: Treatment of the antiphospholipid syndrome. N Engl J Med 2003;349:1177-1179.
33. Derksen RHWM, Khamasta MA, Branch DW: Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004;50:1028-1039.
34. Soulier JP, Boffa MC: Avortement à répétition, thromboses, et anticoagulant circulant antithromboplastine. Nouv Presse Med 1980;9:859-864.
35. Branch DW, Silver RM: Criteria for antiphospholipid syndrome: Early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996;5:409-413.
36. El-Roeiy A, Gleicher N, Friberg J, Myers A: Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987;70:163-170.
37. Geva E, Amit A, Lerner-Geva L, Lessing JB, Yaron Y: Autoimmune disorders: Another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod 1995;10:2560-2563.
38. Kwak JYH, Gilman-Sachs A, Beaman KD, Beer AE: Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology. J Reprod Immunol 1992;22:15-31.
39. Mardesic T, Ulcova-Gallova Z, Huttelova R, Muller P, Voboril J, Hulvert J: The influence of different types of antibodies on in vitro fertilization results. Am J Reprod Immunol 2000;43:1-5.
40. Gleicher N: Antiphospholipid antibodies and reproductive failure: What they do and what they do not do; how to, and how not to treat. Hum Reprod 1997;12:13-16.
41. Sedlakova A, Elzeinova F, Bukovsky A, Madar J, Ulcova-Gallova Z, Peknicova J: Application of monoclonal antibodies against trophoblastic cells to study female infertility. Am J Reprod Immunol 2004;51:482-483.
42. Christiansen OB, Ulcova-Gallova Z, Mohapeloa H, Krauz V: Studies on associations between human leucocyte antigen (HLA) class II and antiphospholipid antibodies in Danish and Czech women with recurrent miscarriages. Hum Reprod 1998;13:3326-3331.
43. Ulcova-Gallova Z, Novakova P, Babcova K, Micanova Z, Bibkova K, Rokyta Z: Early pregnancy loss after repeated IVF and autoantibodies against prothrombin, annexin V and other six various phospholipids. Am J Reprod Immunol 2004;51:470.
44. Dmowski WP, Rana N, Michalowska J: The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer rates. Fertil Steril 1995;63:555-562.
45. Ulcova-Gallova Z, Bouse V, Svabek L, Turek J, Rokyta Z: Endometriosis in reproductive immunology. Am J Reprod Immunol 2002;47:269-274.
46. Ulcova-Gallova Z: Diagnosis Infertility - The Attack of Antibodies. Prague, Petrklic, 1999, pp 1-99.
47. Haimovici F, Andesros J, Racowsky C, Bates W, Fichorova R: Cytokines with key role in reproduction may be modulated by psychopathology and may influence IVF outcome. Am J Reprod Immunol 2004;51:468-469.
48. Rai RM, Cohen H, Dave M, Regan L: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. Br Med J 1997;314:253-257.
49. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L: Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-1323.
50. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A: Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993;169:1411-1417.
51. Ulcova-Gallova Z, Krauz V, Rokyta R: Six kinds of anti-phospholipid antibodies (aPls) in ovulatory mucus and seminal plasma from couples with repeated miscarriages. Int J Fertil 2000;45:321-326.
52. Ulcova-Gallova Z, Bouse V, Krizanovska K, Balvin M, Rokyta Z, Netrvalova L: Beta2-glycoportein I is a good indicator of certain adverse pregnancy conditions. Int J Fertil 2001;46:304-308.